Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q1 2022 Earnings Conference Call May 3, 2022 8:00 AM ET
Company Participants
Tiffany Aldrich - Senior Manager, Corporate Communications
Sheldon Koenig - President and Chief Executive Officer
Joanne Foody - Chief Medical Officer
Eric Warren - Chief Commercial Officer
BJ Swartz - Chief Strategy Officer
Conference Call Participants
Serge Belanger - Needham
Jason Butler - JMP Securities
Jessica Fye - JPMorgan
Jeff Hung - Morgan Stanley
Joseph Thome - Cowen
Paul Choi - Goldman Sachs
Emanuela Branchetti - H.C. Wainwright
Judah Frommer - Credit Suisse
Operator
Ladies and gentlemen, thank you for standing by and welcome. [Operator Instructions] Please be advised that today’s conference call may be recorded. I would now like to hand the conference over to Tiffany Aldrich, Senior Manager in Corporate Communications at Esperion. Please go ahead.
Tiffany Aldrich
Thank you. Good morning and welcome to Esperion’s first quarter 2022 financial results and company update conference call. I am Tiffany Aldrich and I’m part of the Corporate Communications team here at Esperion.
I want to remind callers that the information discussed on the call today is covered under the Safe Harbor provisions of the Private Securities Litigation Reform Act. I caution listeners that management will be making forward-looking statements. Actual results could differ materially from those stated or implied by our forward-looking statements due to risks and uncertainties associated with the business. These forward-looking statements are qualified in their entirety by the cautionary statements contained in today’s press release and our SEC filings.
The content of this conference call contains time-sensitive information that is accurate only as of the date of this live broadcast, May 3, 2022. We undertake no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this conference call and webcast. As a reminder, this conference call and webcast are being recorded and archived. We issued a press release this morning detailing the content of today’s call. A copy can be found at www.esperion.com within the Investors and Media section. We will begin with prepared comments and then open the call for your question. Following today’s call, the team will be available for follow-up questions. Please e-mail corporateteam@esperion.com to schedule time to speak with the team.
With us today are Sheldon Koenig, President and CEO; Dr. Joanne Foody, Chief Medical Officer; Eric Warren, Chief Commercial Officer; and BJ Swartz, Chief Strategy Officer. I will now turn the call over to Sheldon for some prepared remarks. Sheldon?